Paul Dykewicz
Contrarian Investing Includes Ways to Profit from Gold
Contrarian investing includes ways to profit from gold for investors willing to consider an asset that has been out of favor in recent times. One hotspot for investment ideas is the annual FreedomFest conference. FreedomFest and the Global Financial Summit were held in South Dakota for the first time this year, and the event was […]
Six Oil Stocks to Buy as the Economy Improves and Energy Prices Rise
Six oil investments to buy as the economy improves and energy prices rise are part of an industry that recently led BoA Global Research to forecast Brent crude soaring to $100 a barrel by 2022. The six oil stocks to buy amid the recovering economy and increasing oil prices include the country’s biggest refiner of […]
Three Generic Pharmaceutical Manufacturing Stocks to Buy for Profitable Investing
Three generic pharmaceutical manufacturers to buy for profitable investing opportunities feature companies that have risen near the top of that sector. The three generic pharmaceutical manufacturers to buy include two dividend payers and offer the potential that they all could produce further growth organically and through acquisition. The trade-off is that the three generic pharmaceutical […]
Five Biopharmaceutical Stocks to Buy to Gain From Genetic Advances
Five biopharmaceutical stocks to buy to seize upon genetic advances still appear to have room for plenty of appreciation, according to seasoned market trackers who I asked to provide recommendations. The five biopharmaceutical stocks to buy to tap into genetic research inroads include companies that collectively are seeking to find effective treatments for amyotrophic lateral […]
Five Biopharmaceutical Stocks to Buy for Profits Amid the Pandemic
Five biopharmaceutical stocks to buy offer investors a chance to profit while supporting companies that develop treatments for health problems through biological solutions. The five biopharmaceutical stocks to buy are part of an industry that generally is well-financed, with companies backed by an average of 3.5 years of cash to fund research and development (R&D) […]
Seven Pharmaceutical Stocks to Buy for Future Profitability
Seven pharmaceutical stocks to buy in pursuit of future profitability range from established industry behemoths to a promising smaller company that is reaching for big growth while incurring heightened risk. The seven pharmaceutical stocks to buy should only be helped by global spending on medicines projected to grow at a 3-6% compound annual growth rate […]